These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 415557)

  • 1. Sequelae of metrizamide myelography in 200 examinations.
    Baker RA; Hillman BJ; McLennan JE; Strand RD; Kaufman SM
    AJR Am J Roentgenol; 1978 Mar; 130(3):499-502. PubMed ID: 415557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of metrizamide for neuroradiology in chilren.
    Swick HM; Sty JR; Haughton VM
    Ann Neurol; 1978 May; 3(5):409-15. PubMed ID: 310277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Side effects of cervical myelography/radiculography with metrizamide (Amipaque)].
    Lesak F
    Ugeskr Laeger; 1986 Nov; 148(47):3134-6. PubMed ID: 3810908
    [No Abstract]   [Full Text] [Related]  

  • 4. Iopamidol and metrizamide for myelography: prospective double-blind clinical trial.
    Witwer G; Cacayorin ED; Bernstein AD; Hubballah MY; Yuan HA; Kieffer SA
    AJR Am J Roentgenol; 1984 Oct; 143(4):869-73. PubMed ID: 6382981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric myelography with metrizamide.
    Fitz CR; Harwood-Nash DC; Barry JF; Byrd SE
    Acta Radiol Suppl; 1977; 355():182-92. PubMed ID: 299668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Side effects of metrizamide (Amipaque) cervical myelography (author's transl)].
    Okada K; Nishimatsu T; Wada H; Komatsu T
    No Shinkei Geka; 1982 May; 10(5):511-8. PubMed ID: 7110515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of dehydration on the side effects of metrizamide myelography.
    Eldevik OP; Nakken KO; Haughton VM
    Radiology; 1978 Dec; 129(3):715-6. PubMed ID: 152937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lumbar myelography with iohexol and metrizamide: a comparative multicenter prospective study.
    Kieffer SA; Binet EF; Davis DO; Gabrielsen TO; Kido DK; Latchaw RE; Turski PA; Shaw DD
    Radiology; 1984 Jun; 151(3):665-70. PubMed ID: 6371890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amipaque myelography. The side effects compared with Dimer X.
    Ahlgren P
    Neuroradiology; 1975 Aug; 9(4):197-202. PubMed ID: 1186965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast agents for myelography: clinical and radiological evaluation of Amipaque and Pantopaque.
    Kieffer SA; Binet EF; Esquerra JV; Hantman RP; Gross CE
    Radiology; 1978 Dec; 129(3):695-705. PubMed ID: 103130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychologic reactions and other side effects after metrizamide myelography.
    Hauge O; Falkenberg H
    AJR Am J Roentgenol; 1982 Aug; 139(2):357-60. PubMed ID: 6979893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lumbar myelography with iohexol and metrizamide. A comparative multicenter prospective study.
    Kieffer SA; Binet EF; Davis DO; Gabrielsen TO; Kido DK; Latchaw RE; Turski PA; Shaw DD
    Invest Radiol; 1985; 20(1 Suppl):S22-30. PubMed ID: 3882614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurologic complications in diabetics after metrizamide lumbar myelography.
    Steiner E; Simon JH; Ekholm SE; Erickson J; Kido DK; Okawara S
    AJR Am J Roentgenol; 1986 May; 146(5):1057-60. PubMed ID: 3485900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium.
    Shaw DD; Bach-Gansmo T; Dahlstrom K
    Invest Radiol; 1985; 20(1 Suppl):S44-50. PubMed ID: 3882616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumbar myelography today. Experience with metrizamide, a water-soluble, non-ionic contrast medium.
    Sage MR; Benness GT; Perrett LV; Mansfield J
    Med J Aust; 1981 Feb; 1(4):175-6. PubMed ID: 7015091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient metrizamide myelography: prospective evaluation of safety and cost effectiveness.
    Badami JP; Baker RA; Scholz FJ; McLaughlin M
    Radiology; 1986 Jan; 158(1):175-7. PubMed ID: 3079624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of adverse effects following metrizamide myelography in nonambulatory and ambulatory patients.
    Sykes RH; Wasenaar W; Clark P
    Radiology; 1981 Mar; 138(3):625-7. PubMed ID: 7465839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of Metrizamide (amipaque) myelography.
    Stewart JR; Thorne RP
    Orthop Nurs; 1985; 4(4):53-4. PubMed ID: 2981040
    [No Abstract]   [Full Text] [Related]  

  • 19. Myelography with metrizamide--an analysis of the complications encountered in cervical, thoracic and lumbar myelography.
    McCormick CC; ApSimon HT; Chakera TM
    Aust N Z J Med; 1981 Dec; 11(6):645-50. PubMed ID: 6949540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metrizamide myelography for cervical spinal cord injuries.
    Leo JS; Bergeron RT; Kricheff II; Benjamin MV
    Radiology; 1978 Dec; 129(3):707-11. PubMed ID: 725046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.